NR3C2 and hydrops fetalis: The HF+ group participants significantly more often received beta-blockers, alfa1-blockers (only by men), digoxin, ACEI/ARB, oral anticoagulants, and diuretics (significantly more loop diuretics and aldosterone receptor antagonists).